Oxford Biomedica plc (FRA:OXOA)

Germany flag Germany · Delayed Price · Currency is EUR
6.95
-0.05 (-0.71%)
At close: Dec 5, 2025
37.62%
Market Cap 854.53M
Revenue (ttm) 176.41M
Net Income (ttm) -43.24M
Shares Out n/a
EPS (ttm) -0.42
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 74
Open 6.95
Previous Close 7.00
Day's Range 6.95 - 6.95
52-Week Range 2.44 - 7.60
Beta n/a
RSI 51.07
Earnings Date Dec 24, 2025

About Oxford Biomedica

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and de... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1996
Employees 850
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol OXOA
Full Company Profile

Financial Performance

In 2024, Oxford Biomedica's revenue was 128.80 million, an increase of 43.84% compared to the previous year's 89.54 million. Losses were -43.19 million, -72.58% less than in 2023.

Financial numbers in GBP Financial Statements

News

There is no news available yet.